Searchable abstracts of presentations at key conferences in endocrinology

ea0083ao5 | Adrenal and Cardiovascular | EYES2022

Bilateral primary aldosteronism prediction by Integer scoring system

L Sambula , N Matas , A Barac Nekic , K Zibar Tomsic

Background: Adrenal venous sampling (AVS) is the gold standard to differentiate patients with unilateral primary aldosteronism (UPA) from those with bilateral disease (BPA).Objective: The aim of this study was to evaluate the efficiency of using the online Integer scoring system in predicting BPA, as a possible surrogate for AVS.Methods: We performed a retrospective analysis of 105 patients (66 female, median age at diagnosis 53 ye...

ea0083ao6 | Adrenal and Cardiovascular | EYES2022

Adrenal venous sampling in tertiary centre from 2015 to 2022

N Matas , L Sambula , A Barac Nekic , K Zibar Tomsic

Background: Adrenal venous sampling (AVS) is considered the gold standard for differentiating an aldosterone- producing adenoma (aPA) from bilateral adrenal hyperplasia (BAH).Objective: The aim of this study is to present our experience with this method in our hospital.Methods: We performed a retrospective analysis of 105 patients who underwent the AVS protocol at our centre between 2015 and 2022 for PA.Resul...

ea0083erco3 | Endocrine-related Cancer | EYES2022

Hypothalamus-pituitary-adrenal axis recovery after adjuvant mitotane treatment in patients with adrenocortical carcinoma - a retrospective study

A Barac Nekic , K Zibar Tomsic , L Sambula , I. D. Vodanovic , T. Dusek , D. Kastelan

Introduction: Mitotane is an adrenolytic drug which is used in patients with adrenocortical carcinoma (ACC) and leads to adrenal insufficiency (AI). The aim of this study was to evaluate the time to recovery of the hypothalamus-pituitary-adrenal (HPA) axis after adjuvant mitotane treatment and to determine possible predictive factors.Materials and Methods: In this retrospective study, we included 19 patients with ACC, ENSAT stage I- III, who were treated...